China's first independently developed high-current electron accelerator radiopharmaceutical platform
Breaking the dependency on imported isotopes and empowering a new revolution in tumor diagnosis and treatment with cutting-edge technology
Core Advantage
Fill the global capacity gap
The global annual production capacity of Ac-225 is only 1.7 Ci, far from meeting clinical demand. Yao plans to achieve a mass production of 3 Ci by 2026, taking the lead in breaking through the supply bottleneck.
100% independently developed accelerator
Independently designed a side-coupled standing-wave linear accelerator with a power of 200kW, reaching the highest level internationally among similar products, with a cost only 1/6 of that of similar foreign products.
Full-cycle cash flow coverage
Short-term revenue generation through industrial irradiation, medium-term mass production and supply of isotopes, long-term nuclear medicine CRDMO platform — a three-stage business structure ensuring continuous revenue generation capability.
The company focuses on the construction of high-energy, high-current electron accelerators and target station systems, paving the way for the large-scale production of key radionuclides such as Ac-225 and Cu-67.
Read moreIndustry Pain Points and Yao Acceleration Solutions
Over 80% of isotopes rely on imports
Independent accelerators achieve domestic substitution, breaking free from reliance on overseas supply chains
Reactor route is inefficient and costly
The electron accelerator route can produce 2-4 Ci of Ac-225 within 10 days, reducing purification costs by 60%
Nuclear medicine drug development lacks a stable supply of raw materials
Provide a stable supply of isotopes and customized RDC research and development services, offering one-stop empowerment for radiopharmaceutical companies
100% independently developed accelerator, the country's first high-current electron accelerator
国内首个强流电子加速器，功率200kW（国际同类最高）。构建"高能电子加速器 + 靶站照射系统 + 放化分离工艺"一体化平台，推动锕系核素与诊疗一体核素的规模化制备与工程化落地。
Other Apps
View all apps
High-Power Sterilization / Material Modification
Meet the large-scale irradiation needs for medical devices, consumables, and material modification.
Irradiation of industrial components
For component reliability verification and high-standard protection applications.
Nuclear medicine production
Provide stable production capacity for radionuclides used in both diagnosis and therapy.